Abstract
Efficacy and Safety of Once-Weekly vs Twice-Weekly Carfilzomib Plus Dexamethasone: Subgroup Analysis of the Phase 3 A.R.R.O.W. Study (NCT02412878) By Prior Lines
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have